U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337967) titled 'Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms' on Dec. 13, 2025.
Brief Summary: Reticulocyte parameters as early indicators of bone marrow erythropoietic activity in chronic B lymphoproliferative neoplasms
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
B Chronic Lymphocytic Leukemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Huda Ahmed Abdelsabour Abdelwahab
Information provided by (Responsible Party): Huda Ahmed Abdelsabour Abdelwahab, Assiut University
Published by HT Digital Content Services with permission from Health Dai...